Skip to main content
. 2023 Dec 4;18:379. doi: 10.1186/s13023-023-02980-3

Table 3.

22q11DS caregivers perception of healthcare services

How do you rate the healthcare services for 22q11DS children Very bad Rather bad I do not know Rather good Very good
Support for caregivers from government and social institutions 10(22.7) 17(38.6) 5(11.4) 10(22.7) 2(4.5)
Quality of medical care for your 22q11DS child 1(2.3) 14(31.8) 7(15.9) 20(45.4) 2(4.5)
Access to specialists (neurologist, geneticist, genetic clinic, psychologist 9(20.5) 20(45.4) 2(4.5) 12(27.3) 1(2.3)
Access to medications for 22q11DS children 19(43.2) 15(34.1) 7(15.9) 2(4.5) 1(2.3)
Access to and financial help with rehabilitation for 22q11DS children 2(4.5) 7(15.9) 11(25) 14(31.8) 10(22.7)
Access to information on 22q11DS 14(31.8) 16(36.4) 3(6.8) 9(20.5) 2(4.5)
Support for 22q11DS children and caregivers from healthcare professionals 9(20.5) 16(36.4) 8(18.2) 10(22.7) 1(2.3)
Physicians’ knowledge about 22q11DS 17(38.6) 19(43.2) 2(4.5) 6(13.6) 0(0)
Physicians’ practical information about 22q11DS(how to provide care for your 22q11DS child; how to perform various tasks) 14(31.8) 14(31.8) 11(25) 5(11.4) 0(0)
Physician’s/neurologist’s/geneticist’s communication skills 5(11.4) 13(29.5) 4(9.1) 21(47.7) 1(2.3)
Support caregivers receive from physicians 9(20.5) 13(29.5) 12(27.3) 9(20.5) 1(2.3)
Physicians’ empathy 5(11.4) 12(27.3) 7(15.9) 18(40.9) 2(4.5)
Drug and healthcare expenses 7(15.9) 5(11.4) 15(34.1) 7(15.9) 10(22.7)
Adaption of home to the child’s needs 21(47.7) 12(27.3) 5(11.4) 2(4.5) 4(9.1)
Lack of access specialised care equipment 16(36.4) 13(29.5) 10(22.7) 3(6.8) 2(4.5)
Drug reimbursement or purchase of drugs 16(36.4) 13(29.5) 9(20.5) 2(4.5) 4(9.1)
Contact with genetic clinic 3(6.8) 6(13.6) 10(22.7) 24(54.5) 1(2.3)
Contact with psychological clinic 3(6.8) 8(18.2) 16(36.4) 14(31.8) 3(6.8)
Contacts with the healthcare system 1(2.3) 3(6.8) 21(47.7) 10(22.7) 9(20.5)